Segment Data (Tables)

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Summary of Net Sales and Other Information by Segment

Net sales and other information by segment is as follows (in millions):

	Americas		EMEA		Asia Pacific		Product Category Operating Segments		Global Operations and Corporate Functions			Total
As of and for the Year Ended December 31, 2015
Net sales	$	3,109.4	$	1,302.9	$	881.6	$	703.9	$	–		$	5,997.8
Depreciation and amortization		110.0		61.1		37.9		21.0		482.4			712.4
Segment operating profit		1,647.0		445.3		421.9		167.9		(689.1	)		1,993.0
Inventory step-up and certain other inventory and manufacturing related charges													(348.8	)
Intangible asset amortization													(337.4	)
Certain claims													(7.7	)
Special items
Biomet merger related													(619.1	)
Other special items													(212.7	)
Operating profit													467.3
Total assets		1,525.0		1,382.2		642.4		788.3		22,881.6			27,219.5
Additions to instruments		1.6		0.2		4.7		22.8		237.1			266.4
Additions to other property, plant and equipment		21.7		3.4		9.0		4.6		129.0			167.7
As of and for the Year Ended December 31, 2014
Net sales	$	2,320.2	$	1,189.1	$	789.2	$	374.8	$	–		$	4,673.3
Depreciation and amortization		70.5		46.0		30.2		7.5		221.6			375.8
Segment operating profit		1,215.4		435.6		371.0		76.5		(569.8	)		1,528.7
Inventory step-up and certain other inventory and manufacturing related charges													(36.3	)
Intangible asset amortization													(92.5	)
Certain claims													(21.5	)
Special items
Biomet merger related													(61.9	)
Other special items													(279.2	)
Operating profit													1,037.3
Total assets		1,012.0		924.0		380.3		295.1		7,046.6			9,658.0
Additions to instruments		0.2		0.1		6.0		16.3		174.8			197.4
Additions to other property, plant and equipment		8.6		2.1		9.1		2.6		122.5			144.9
As of and for the Year Ended December 31, 2013
Net sales	$	2,347.6	$	1,134.0	$	771.9	$	369.9	$	–		$	4,623.4
Depreciation and amortization		62.6		48.2		30.0		7.7		210.0			358.5
Segment operating profit		1,293.5		401.2		335.6		79.9		(617.1	)		1,493.1
Inventory step-up and certain other inventory and manufacturing related charges													(88.7	)
Intangible asset amortization													(78.5	)
Certain claims													(47.0	)
Special items
Biomet merger related													–
Other special items													(210.3	)
Operating profit													1,068.6
Total assets		947.9		974.5		375.9		322.9		6,973.8			9,595.0
Additions to instruments		0.2		0.3		6.5		14.9		171.0			192.9
Additions to other property, plant and equipment		8.7		1.2		7.6		4.6		77.9			100.0

Disclosure on Geographic Areas, Long-Lived Assets

We conduct business in the following countries that hold 10 percent or more of our total consolidated Property, plant and equipment, net:

As of December 31,	2015		2014		2013
United States	$	1,188.6	$	794.4	$	737.6
Switzerland		200.9		198.7		211.5
Other countries		673.1		292.2		280.4
Property, plant and equipment, net	$	2,062.6	$	1,285.3	$	1,229.5

Summary of Net Sales by Product Category

Net sales by product category are as follows (in millions):

For the Years Ended December 31,	2015		2014		2013
Knees	$	2,276.8	$	1,895.2	$	1,862.2
Hips		1,537.2		1,326.4		1,330.5
S.E.T.		1,214.9		863.2		847.2
Dental		335.7		242.8		239.3
Spine & CMF		404.4		207.2		202.3
Other		228.8		138.5		141.9
Total		5,997.8		4,673.3		4,623.4